Phase II Study of Intraperitoneal Paclitaxel Plus Cisplatin and Intravenous Paclitaxel Plus Bevacizumab As Adjuvant Treatment of Optimal Stage II/III Epithelial Ovarian Cancer von Konner, Jason A., Grabon, Diana M., Gerst, Scott R., Iasonos, Alexia, Thaler, Howard, Pezzulli, Sandra D., Sabbatini, Paul J., Bell-McGuinn, Katherine M., Tew, William P., Hensley, Martee L., Spriggs, David R., Aghajanian, Carol A.

Volltext

A Phase I Trial of the Novel Proteasome Inhibitor PS341 in Advanced Solid Tumor Malignancies von AGHAJANIAN, Carol, SOIGNET, Steven, CANALES, Christina, DAUD, Adil, SPRIGGS, David R, DIZON, Don S, PIEN, Christine S, ADAMS, Julian, ELLIOTT, Peter J, SABBATINI, Paul, MILLER, Vincent, HENSLEY, Martee L, PEZZULLI, Sandra

Volltext

Phase I and Pharmacokinetic Study of the Novel Oral Cell-Cycle Inhibitor Ro 31-7453 in Patients With Advanced Solid Tumors von DUPONT, Jakob, BIENVENU, Bryan, BREIMER, Lars, JIANGUO ZHI, DEMARIO, Mark, SPRIGGS, David, SOIGNET, Steven L, AGHAJANIAN, Carol, PEZZULLI, Sandra, SABBATINI, Paul, VONGPHRACHANH, Phothisath, CHANG, Christine, PERKELL, Christina, NG, Kenneth, PASSE, Sharon

Volltext